12-121440040-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000377071.9(KDM2B):c.3646G>A(p.Val1216Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,612,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1216L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000377071.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM2B | NM_032590.5 | c.3646G>A | p.Val1216Met | missense_variant | 22/23 | ENST00000377071.9 | NP_115979.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM2B | ENST00000377071.9 | c.3646G>A | p.Val1216Met | missense_variant | 22/23 | 1 | NM_032590.5 | ENSP00000366271.3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000102 AC: 25AN: 244304Hom.: 0 AF XY: 0.0000904 AC XY: 12AN XY: 132672
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1459862Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726084
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74486
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2022 | The c.3646G>A (p.V1216M) alteration is located in exon 22 (coding exon 22) of the KDM2B gene. This alteration results from a G to A substitution at nucleotide position 3646, causing the valine (V) at amino acid position 1216 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at